Millennials: Here’s Why You Shouldn’t Gamble on Marijuana Stocks

While you might be tempted to gamble on weed stocks like CannTrust Holdings Inc (TSX:TRST)(NYSE:CTST), it’s not a good idea

Overhead shot of young adults using technology at a table

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

Marijuana stocks are extremely popular with millennials. That’s the inference of data from the millennial-dominated trading app Robinhood, which recently revealed that marijuana stocks made up two of the nine most popular stocks on its platform.

Two out of nine is 22%, making marijuana stocks much more widely owned on Robinhood than in the markets overall. Robinhood does not represent all millennial investors, but as an app with mostly millennial users, there is strong overlap between its user base and that age cohort.

Unfortunately for millennials, marijuana stocks are tanking this year. Aurora Cannabis, the most popular stock on Robinhood, is down 5% to date, and other marijuana stocks, like CannTrust Holdings Inc (TSX:TRST)(NYSE:CTST) are down as much as 75%.

Although you could have made money by buying marijuana stocks early, you’d have lost money by buying even the best-performing marijuana stocks this year.

If you’re a millennial investor, you may find yourself swayed by the hype surrounding weed stocks. If you feel that’s the case, it’s best to resist the urge to take the dive. Here’s why:

They’re extremely volatile

Beta is a measure of the volatility of a stock; that is, how dramatically it swings up and down compared to the market as a whole. The higher a stock’s beta coefficient, the bumpier your ride will be–and marijuana stocks are nothing if not volatile.

Over the past three years, CannTrust Holdings has had a beta coefficient of 4.62, meaning it’s more than four times as volatile as the market. Put simply, if you buy TRST, you’re going to have a bumpy ride–and if present trends continue, you’ll mostly lose money in the long run.

The fact that marijuana stocks are trending downward is alarming in itself. However, even if you buy a weed stock that’s a long-term winner, you could easily lose money by panic selling on downswings.

The psychology of panic selling

Loss aversion refers to the tendency of people to fear losses more than they desire gains. It’s the psychological principle underlying the phenomenon of panic selling, whereby investors sell on downswings even if their long term prospects are good.

Studies show that people are about twice as averse to losses as they are keen for gains. In other words, not losing $10 is better than getting $10.

The psychology of panic selling is something all investors have to keep in mind. But with marijuana stocks, it’s particularly important to be wary of–and probably a reason to avoid the asset class altogether.

As a case in point, we can look at Aphria Inc. Unlike CannTrust, Aphria is not overwhelmingly bearish right now. After a surprise earnings report that showed operating profits and a 969% year-over-year revenue growth rate, it has traded mostly flat.

However, even with a better long-term trend than CannTrust, it’s still not safe for those susceptible to loss aversion. With a beta coefficient of 3.7,  it’s nearly as volatile as CannTrust, which means it sees plenty of dramatic swings that could trigger panic selling.

This is a problem because even if the stock rises over the long term, it has the potential to trigger psychology that could cost you money.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »